Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Omori T, Miyata H.
Sugase T, et al. Among authors: omori t.
Anticancer Res. 2024 Jan;44(1):185-193. doi: 10.21873/anticanres.16801.
Anticancer Res. 2024.
PMID: 38159967